Publicaciones en las que colabora con Javier Ariza Cardenal (30)

2023

  1. Vertebral osteomyelitis after spine instrumentation surgery: risk factors and management

    Journal of Hospital Infection, Vol. 140, pp. 102-109

2021

  1. Implant removal in the management of prosthetic joint infection by staphylococcus aureus: Outcome and predictors of failure in a large retrospective multicenter study

    Antibiotics, Vol. 10, Núm. 2, pp. 1-13

  2. Prosthetic shoulder joint infection by Cutibacterium acnes: Does rifampin improve prognosis? A retrospective, multicenter, observational study

    Antibiotics, Vol. 10, Núm. 5

2020

  1. Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 26, Núm. 4, pp. 499-505

2019

  1. The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms

    Journal of Clinical Medicine, Vol. 8, Núm. 5

2018

  1. Erysipelas or cellulitis with a prosthetic joint <em>in situ</em>

    Journal of Bone and Joint Infection, Vol. 3, Núm. 4, pp. 222-225

2017

  1. The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: The results of a large multicenter study

    Clinical Infectious Diseases, Vol. 64, Núm. 12, pp. 1742-1752

2016

  1. Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial

    International Journal of Antimicrobial Agents, Vol. 48, Núm. 3, pp. 310-316

  2. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 732.e1-732.e8

2014

  1. Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: A multi-national study

    Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. 1219-1224

  2. Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study

    Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. O911-O919

2013

  1. A large multicenter study of methicillin-susceptible and methicillin-resistant staphylococcus aureus prosthetic joint infections managed with implant retention

    Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 182-194

  2. Infected hip hemiarthroplasties and total hip arthroplasties: Differential findings and prognosis

    Journal of Infection, Vol. 67, Núm. 6, pp. 536-544

  3. Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria

    Diagnostic Microbiology and Infectious Disease, Vol. 76, Núm. 1, pp. 93-98

2011

  1. Changing Trends in the Epidemiology of Pyogenic Vertebral Osteomyelitis: The Impact of Cases with No Microbiologic Diagnosis

    Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 2, pp. 247-255

  2. Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections

    Journal of Infection, Vol. 63, Núm. 1, pp. 23-31

  3. Early prosthetic joint infection: Outcomes with debridement and implant retention followed by antibiotic therapy

    Clinical Microbiology and Infection, Vol. 17, Núm. 11, pp. 1632-1637

  4. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus

    Journal of Infection, Vol. 63, Núm. 3, pp. 229-235

2010

  1. Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5251-5256

2009

  1. Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 10, pp. 4252-4257